Prophylactic treatment with nadroparin in pregnancy and puerperium

Prophylactic treatment with nadroparin in pregnancy and puerperium

Risk factors during pregnancy and puerperium in patients under prophylactic treatment with Nadroparin

Versandkostenfrei!
Versandfertig in 6-10 Tagen
29,99 €
inkl. MwSt.
PAYBACK Punkte
15 °P sammeln!
Venous thromboembolic disease, such as deep vein thrombosis and pulmonary thromboembolism, are important causes of maternal mortality and have been considered a public health problem.The incidence increases 2 to 4 times during pregnancy, being higher in cesarean delivery than in vaginal delivery. The disease has a higher incidence in the left leg. Another predisposing factor reported is that of decreased flow in the left leg when the pregnant woman adopts a supine position.The results of studies of risk factors in pregnant women to suffer thromboembolic phenomena are presented.